Covidien's DVT compression system gets FDA green light
This article was originally published in Clinica
Executive Summary
The US FDA has granted 510(k) clearance for Covidien's Kendall SCD sequential compression comfort sleeve and Kendall SCD 700 series controller. The devices are designed to reduce the incidence of deep vein thrombosis (DVT) and pulmonary embolism, while avoiding the risk of bleeding found with anticoagulant drugs. The device is more comfortable than older systems, Mansfield, Massachusetts-based Covidien says, and addresses problems such as sweating, heat, itchiness and skin irritation. A 148-patient trial found that 84% preferred the new product over Covidien's older Kendall SCD Express sleeve.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.